Staging and response to therapy of malignant pleural mesothelioma Journal Article


Author: Heelan, R.
Article Title: Staging and response to therapy of malignant pleural mesothelioma
Abstract: Earlier staging systems tended to concentrate on advanced malignant pleural mesothelioma (MPM) and considerable variation arose among the different systems. This was addressed in 1997 when the International Mesothelioma Interest Group (IMIG) staging system was approved. This is not a perfect system as many of the distinctions it makes cannot be identified by current computed tomography (CT) and magnetic resonance imaging (MRI) scanning. However presurgical staging using CT and MRI can be useful in delineating the extent and volume of disease and in detecting unexpected advanced disease as well as alerting clinicians to the possibility of early stage malignant pleural mesothelioma. Patients response to therapy can be measured using the response evaluation criteria in solid tumors (RECIST) criteria involving multiple measurements of a single diameter of tumour thickness. © 2004 Elsevier Ireland Ltd. All rights reserved.
Keywords: cancer chemotherapy; treatment outcome; cancer surgery; conference paper; cancer radiotherapy; cancer staging; nuclear magnetic resonance imaging; magnetic resonance imaging; antineoplastic agent; neoplasm staging; computer assisted tomography; tomography, x-ray computed; malignant mesothelioma; mesothelioma; malignant pleural mesothelioma; pleural neoplasms; recist criteria; international cooperation; computed tomography (ct); magnetic resonance imaging (mri); pet scanning; humans; prognosis; human; priority journal; imig staging system
Journal Title: Lung Cancer
Volume: 45
Issue: Suppl.
ISSN: 0169-5002
Publisher: Elsevier Ireland Ltd.  
Date Published: 2004-08-01
Start Page: S59
End Page: S61
Language: English
DOI: 10.1016/j.lungcan.2004.04.013
PROVIDER: scopus
PUBMED: 15261435
DOI/URL:
Notes: Lung Cancer -- Cited By (since 1996):10 -- Export Date: 16 June 2014 -- CODEN: LUCAE -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Robert T Heelan
    140 Heelan